BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19647859)

  • 1. Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prospective, placebo-controlled study.
    Van Pachterbeke C; Bucella D; Rozenberg S; Manigart Y; Gilles C; Larsimont D; Vanden Houte K; Reynders M; Snoeck R; Bossens M
    Gynecol Oncol; 2009 Oct; 115(1):69-74. PubMed ID: 19647859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III).
    Snoeck R; Noel JC; Muller C; De Clercq E; Bossens M
    J Med Virol; 2000 Feb; 60(2):205-9. PubMed ID: 10596022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerance of cidofovir as a 2% gel for local application in high-grade cervical intraepithelial neoplasia: A phase 1 investigation.
    Bossens M; Jost M; Van Pachterbeke C; De Maertelaer V; Simon P; Frankenne F; Hubert P; Evrard B; Snoeck R
    Int J Clin Pharmacol Ther; 2018 Mar; 56(3):134-141. PubMed ID: 29319498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical Imiquimod for the Treatment of High-Grade Squamous Intraepithelial Lesions of the Cervix: A Randomized Controlled Trial.
    Fonseca BO; Possati-Resende JC; Salcedo MP; Schmeler KM; Accorsi GS; Fregnani JHTG; Antoniazzi M; Pantano NP; Santana IVV; Matsushita GM; Dos Reis R
    Obstet Gynecol; 2021 Jun; 137(6):1043-1053. PubMed ID: 33957649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cold-knife conization versus photodynamic therapy with topical 5-aminolevulinic acid (5-ALA) in cervical intraepithelial neoplasia (CIN) II with associated human papillomavirus infection: a comparison of preliminary results.
    Bodner K; Bodner-Adler B; Wierrani F; Kubin A; Szölts-Szölts J; Spängler B; Grünberger W
    Anticancer Res; 2003; 23(2C):1785-8. PubMed ID: 12820459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial.
    van de Laar RLO; Hofhuis W; Duijnhoven RG; Polinder S; Melchers WJG; van Kemenade FJ; Bekkers RLM; Van Beekhuizen HJ
    BMC Cancer; 2020 Jun; 20(1):539. PubMed ID: 32517663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial.
    Grimm C; Polterauer S; Natter C; Rahhal J; Hefler L; Tempfer CB; Heinze G; Stary G; Reinthaller A; Speiser P
    Obstet Gynecol; 2012 Jul; 120(1):152-9. PubMed ID: 22914404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial.
    van de Sande AJM; Koeneman MM; Gerestein CG; Kruse AJ; van Kemenade FJ; van Beekhuizen HJ
    BMC Cancer; 2018 Jun; 18(1):655. PubMed ID: 29902979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial.
    Koeneman MM; Kruse AJ; Kooreman LFS; Zur Hausen A; Hopman AHN; Sep SJS; Van Gorp T; Slangen BFM; van Beekhuizen HJ; van de Sande M; Gerestein CG; Nijman HW; Kruitwagen RFPM
    BMC Cancer; 2016 Feb; 16():132. PubMed ID: 26897518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized study of hexaminolevulinate photodynamic therapy in patients with cervical intraepithelial neoplasia 1/2.
    Hillemanns P; Garcia F; Petry KU; Dvorak V; Sadovsky O; Iversen OE; Einstein MH
    Am J Obstet Gynecol; 2015 Apr; 212(4):465.e1-7. PubMed ID: 25467012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization.
    Costa S; De Simone P; Venturoli S; Cricca M; Zerbini ML; Musiani M; Terzano P; Santini D; Cristiani P; Syrjänen S; Syrjänen K
    Gynecol Oncol; 2003 Aug; 90(2):358-65. PubMed ID: 12893200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical interventions for high-grade vulval intraepithelial neoplasia.
    Pepas L; Kaushik S; Nordin A; Bryant A; Lawrie TA
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007924. PubMed ID: 26284429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of high-risk HPV persistence after laser CO2 conization for high-grade CIN: a prospective clinical study.
    Fallani MG; Penna C; Marchionni M; Bussani C; Pieralli A; Andersson KL; Fambrini M
    Eur J Gynaecol Oncol; 2008; 29(4):378-82. PubMed ID: 18714574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial.
    Tristram A; Hurt CN; Madden T; Powell N; Man S; Hibbitts S; Dutton P; Jones S; Nordin AJ; Naik R; Fiander A; Griffiths G
    Lancet Oncol; 2014 Nov; 15(12):1361-8. PubMed ID: 25304851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples.
    Hesselink AT; van den Brule AJ; Brink AA; Berkhof J; van Kemenade FJ; Verheijen RH; Snijders PJ
    Cancer; 2004 Feb; 102(1):11-8. PubMed ID: 14968413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of human papillomavirus infection in cervical intraepithelial neoplasia. A retrospective histopathological study of 317 cases treated by laser conization.
    Lie AK; Skjeldestad FE; Hagen B; Haugen OA
    APMIS; 1995 Oct; 103(10):693-8. PubMed ID: 8534427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial.
    Garcia F; Petry KU; Muderspach L; Gold MA; Braly P; Crum CP; Magill M; Silverman M; Urban RG; Hedley ML; Beach KJ
    Obstet Gynecol; 2004 Feb; 103(2):317-26. PubMed ID: 14754702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia.
    Fambrini M; Penna C; Pieralli A; Bussani C; Fallani MG; Andersson KL; Scarselli G; Marchionni M
    Gynecol Oncol; 2008 Apr; 109(1):59-64. PubMed ID: 18255129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of HPV testing in the follow-up of women treated for cervical dysplasia.
    Ribaldone R; Boldorini R; Capuano A; Arrigoni S; Di Oto A; Surico N
    Arch Gynecol Obstet; 2010 Aug; 282(2):193-7. PubMed ID: 20012636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of human papillomavirus infection between biopsy and excision of cervical intraepithelial neoplasia: results from the ZYC101a protocol.
    Crum CP; Beach KJ; Hedley ML; Yuan L; Lee KR; Wright TC; Urban RG
    J Infect Dis; 2004 Apr; 189(8):1348-54. PubMed ID: 15073670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.